Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study-Reference-Cited by-同舟云学术

Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study

Published:2024-06-03 Issue:8 Volume:50 Page:1228-1239
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Kamel Toufik,Janssen-Langenstein Ralf,Quelven Quentin,Chelly Jonathan,Valette Xavier,Le Minh-Pierre,Bourenne Jeremy,Garot Denis,Fillatre Pierre,Labruyere Marie,Heming Nicholas,Lambiotte Fabien,Lascarrou Jean-Baptiste,Lesieur Olivier,Bachoumas Konstantinos,Ferre Alexis,Maury Eric,Chalumeau-Lemoine Ludivine,Bougon David,Roux Damien,Guisset Olivier,Coudroy Remi,Boulain Thierry^ORCID, ,Johann Auchabie,Pascal Beuret,Cédric Darreau,Isabelle Desmeulles,Christophe Guervilly,Vivien Hong Tuan Ha,Sébastien Jochmans,Mathieu Jozwiak,Guillaume Louis,Jean-Christophe Navellou,Mathilde Neuville,Nicolas Pichon,Anne Sagnier,David Schnell

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00134-024-07489-2.pdf

Reference50 articles.

1. Pereira-Díaz E, Moreno-Verdejo F, de la Horra C, Guerrero JA, Calderón EJ, Medrano FJ (2019) Changing trends in the epidemiology and risk factors of pneumocystis pneumonia in Spain. Front Public Health 7:275. https://doi.org/10.3389/fpubh.2019.00275

2. Grønseth S, Rogne T, Hannula R, Åsvold BO, Afset JE, Damås JK (2021) Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infect Dis 21:659. https://doi.org/10.1186/s12879-021-06144-1

3. Kolbrink B, Scheikholeslami-Sabzewari J, Borzikowsky C, von Samson- Himmelstjerna FA, Ullmann AJ, Kunzendorf U (2022) Schulte K (2022) Evolving epidemiology of pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany. Lancet Reg Health Eur 18:100400. https://doi.org/10.1016/j.lanepe.2022.100400

4. Pates K, Periselneris J, Russell MD, Mehra V, Schelenz S, Galloway JB (2023) Rising incidence of Pneumocystis pneumonia: a population-level descriptive ecological study in England. J Infect 86:385–390. https://doi.org/10.1016/j.jinf.2023.02.014

5. Bienvenu A-L, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11–17

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit. Author’s reply;Intensive Care Medicine;2024-08-15

2. Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit;Intensive Care Medicine;2024-08-05

3. Severe Pneumocystis jirovecii pneumonia: time to reassess our practices;Intensive Care Medicine;2024-07-29

4. Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization;CHEST;2024-07